Healthcare · NSE: PPLPHARMA
Piramal Pharma Limited
₹232.80
+17.15% · close 28 Oct 2026
52-week range
₹133.27 – ₹232.80
From 52W high
0.00%
Return 1Y
+15.19%
Volume · Avg 20D
11.81 Cr · 80.95 L
Returns & technicals
1W+21.76%
1M+10.69%
3M+20.35%
6M+37.93%
1Y+15.19%
| 50-day average | ₹206.78 above |
| 200-day average | ₹176.42 above |
| Volatility (1Y, annualised) | 37.48% |
| RSI (14) | 71.9 overbought |
| MACD histogram (12, 26, 9) | 2.72 |
| Delivery · 20D avg | 15.74% · 40.56% |
| Signals | 52W breakout volume 50.8x |
| Turnover (last day) | ₹2,685 Cr |
Profile
| Symbol | PPLPHARMA |
| ISIN | INE0DK501011 |
| Sector | Healthcare |
| Listed on NSE | 19 Oct 2022 |
| Face value | ₹10 |
| Series | EQ |
Financials & shareholding
Quarterly results, P/E and the shareholding pattern for PPLPHARMA are coming in a later update.
Peers in Healthcare
| Stock | Price | Day | 1M | 1Y |
|---|---|---|---|---|
| SYNGENE Syngene International Limited | ₹410.85 | +12.19% | +8.49% | -37.51% |
| ACUTAAS Acutaas Chemicals Limited | ₹3,710.00 | -2.20% | +13.37% | +116.38% |
| DIVISLAB Divi's Laboratories Limited | ₹9,558.50 | +0.56% | -0.63% | +48.46% |
| ONESOURCE Onesource Specialty Pharma Limited | ₹1,577.60 | -0.77% | -1.56% | -14.00% |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137.00 | +4.43% | -8.46% | +3.25% |
| MAXHEALTH Max Healthcare Institute Limited | ₹851.50 | +0.77% | -16.03% | -27.82% |